Venetolax plus azacitidine is effective maintenance therapy after allogeneic hematopoietic stem cell transplantation in patients with intermediate/high-risk Acute Myeloid Leukemia
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Caixia Wang, Liangliang Wu, Xiaoxuan Xu, Shunqing WANG
Institution: Guangzhou First People's Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417004617
Cites:
Cited by:
Related to: